| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.29B | -6.6% |
| R&D Expense | $27.0M | -35.7% |
| SG&A Expense | $2.03B | -19.6% |
| Operating Income | -$179.6M | -202.5% |
| Pre-tax Income | -$73.1M | +95.1% |
| Income Tax | -$10.4M | +97.2% |
| Net Income | -$62.7M | +94.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $476.1M | +27.4% |
| Short-term Investments | $286K | -96.5% |
| Accounts Receivable | $922.0M | +3.6% |
| Inventory | $303.3M | -39.0% |
| Current Assets | $2.48B | +5.8% |
| Total Assets | $44.19B | -14.0% |
| Current Liabilities | $5.41B | -28.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $745.1M | -62.7% |
| Capital Expenditures | $1.29B | -54.5% |
| Investing Cash Flow | -$814.2M | +73.8% |
| Financing Cash Flow | $337.2M | +223.3% |
| Free Cash Flow | -$541.0M | +35.0% |
| Long-term Debt |
| $20.75B |
| +14.2% |
| Total Liabilities | $38.51B | +12.7% |
| Stockholders' Equity | $5.24B | -68.8% |